HSBC Holdings’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$86.4K Sell
13,846
-91,136
-87% -$447K ﹤0.01% 2822
2026
Q1
$359K Buy
104,982
+81,656
+350% +$275K ﹤0.01% 2373
2025
Q4
$66K Buy
+23,326
New +$120K ﹤0.01% 2841
2024
Q4
Sell
-7,275
Closed -$216K 3091
2024
Q3
$216K Sell
7,275
-23,395
-76% -$585K ﹤0.01% 2561
2024
Q2
$732K Buy
+30,670
New +$720K ﹤0.01% 1805

Other funds holding ASPN

HSBC Holdings's ASPN Position: Q2 2026 in Review

HSBC Holdings reduced its Aspen Aerogels (ASPN) stake by 87% in Q2 2026, selling an estimated $447K and leaving 13,846 shares worth $86.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2822.

HSBC Holdings first reported a position in ASPN in Q2 2024 and has held it in 5 quarters since. The position peaked at $732K in Q2 2024. 180 funds tracked by Wall St. Rank hold ASPN as of Q2 2026.

  • HSBC Holdings held 13,846 shares of Aspen Aerogels worth $86.4K as of Q2 2026.
  • HSBC Holdings sold 91,136 Aspen Aerogels shares in Q2 2026, an estimated $447K.
  • Aspen Aerogels made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2822 holding.
  • HSBC Holdings first reported a position in Aspen Aerogels in Q2 2024 and has held it in 5 quarters since.
  • HSBC Holdings's Aspen Aerogels position peaked at $732K in Q2 2024.
  • 180 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.